Earnings Calls In Brief
This article was originally published in The Gray Sheet
Executive Summary
Hologic 3D mammography
You may also be interested in...
News In Brief
Allergan’s Lap-Band
News In Brief
Allergan’s Lap-Band
FDA OKs Sapien Valve As Pivotal Trial Control Prior To Marketing Approval
Edwards Lifesciences says FDA will support use of the firm's investigational Sapien transcatheter aortic heart valve as a control treatment in an upcoming trial of the firm’s next-generation Sapien XT.